Purchase Order HT001418P0396
Award Date 8/31/18
Potential Completion Date 9/1/18
Potential Value $150K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $151,200.00. The contract is for the provision of ThyroSeq V.2 molecular testing services, which are used for cancer screening and diagnosis. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on delivering ThyroSeq testing to federal agencies, including the Department...
- The Defense Health Agency awarded a $105,000 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on March 22, 2021, for ThyroSeq molecular diagnostic testing services. The contract, which is scheduled for completion by April 30, 2025, will be performed at Fort Belvoir, Virginia. No set-aside designation was used for this award. Cytopath Biopsy Lab Inc. specializes in anatomic pathology and molecular diagnostic laboratory services, with a primary focus on...
- This is a firm fixed price purchase order for $77,440.80 awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Cytopath Biopsy Lab Inc. (doing business as Cblpath) to provide laboratory testing services related to the ThyroSeq V.2 molecular diagnostic test. The award supports the agency's cancer screening and diagnosis programs, particularly for veterans and active military members. Cytopath Biopsy Lab Inc. has provided similar ThyroSeq testing services to...
- This is a firm fixed price purchase order awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of THROSEQ V.2 MOLECULAR TESTING services. The contract has a completion date of September 30, 2017 and a potential value of $150,000.00. Cblpath is a for-profit organization that provides specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis utilizing next-generation...
- This federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, is for $64,400.00 to provide CYTOPATHOLOGY & THYROSEQUENCE TESTING SERVICES. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 30, 2026. The funding agency is the Veterans Integrated Service Network 2, a civilian agency under the U.S. Department of Veterans Affairs. The contract does not have a set-aside designation. Cblpath is a for-profit...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $8,000.00 firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, for thyroid molecular testing services. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with experience delivering ThyroSeq genetic testing to support cancer screening and diagnosis programs for the VA and Department of Defense. This contract is not set aside and is...
- This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the delivery of ThyroSeq molecular diagnostic testing services. The $4,200.00 firm fixed price contract was issued by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12, to support cancer screening and diagnosis programs for veterans. The contract is not set aside and references Cytopath Biopsy Lab Inc.'s prior work providing ThyroSeq genetic testing for...
- This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for...
- This is a federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of specialized thyroid cancer diagnostic testing services to the U.S. Department of Veterans Affairs (VA). The contract, valued at $10,000.00, is a Blanket Purchase Agreement (BPA) call order issued under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. Cytopath Biopsy Lab Inc. will deliver its ThyroSeq molecular diagnostic testing services to support cancer...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq testing kits. The $320,000.00 contract is to deliver specialized thyroid cancer diagnostic testing services, including ThyroSeq analysis of genetic mutations to evaluate malignancy of thyroid nodules, to support screening programs at VA medical centers and associated healthcare networks...